These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6831407)

  • 1. Effects of acivicin and dipyridamole on hepatoma 3924A cells.
    Zhen YS; Lui MS; Weber G
    Cancer Res; 1983 Apr; 43(4):1616-9. PubMed ID: 6831407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
    Fischer PH; Pamukcu R; Bittner G; Willson JK
    Cancer Res; 1984 Aug; 44(8):3355-9. PubMed ID: 6744269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical pharmacology of acivicin in rat hepatoma cells.
    Lui MS; Kizaki H; Weber G
    Biochem Pharmacol; 1982 Nov; 31(21):3469-73. PubMed ID: 7150366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-enzyme-targeted chemotherapy by acivicin and actinomycin.
    Weber G; Prajda N; Lui MS; Denton JE; Aoki T; Sebolt J; Zhen YS; Burt ME; Faderan MA; Reardon MA
    Adv Enzyme Regul; 1982; 20():75-96. PubMed ID: 6180609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage capacity of hepatoma 3924A and action of dipyridamole.
    Weber G; Lui MS; Natsumeda Y; Faderan MA
    Adv Enzyme Regul; 1983; 21():53-69. PubMed ID: 6443595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schedule-dependent synergistic action of tiazofurin and dipyridamole on hepatoma 3924A cells.
    Jayaram HN; Murayama K; Pillwein K; Zhen W; Weber G
    Cancer Chemother Pharmacol; 1992; 31(2):93-6. PubMed ID: 1451238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat hepatomas: chemotherapy with lycurim and pyrazofurin.
    Lui MS; Jackson RC; Harkrader RJ; Weber G
    J Natl Cancer Inst; 1982 Apr; 68(4):665-8. PubMed ID: 6951080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of resistance of a variant of P388 leukemia to L-(alpha S,5S)-alpha-amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin).
    Jayaram HN; Ardalan B; Deas M; Johnson RK
    Cancer Res; 1985 Jan; 45(1):207-12. PubMed ID: 2578092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.
    Willson JK; Fischer PH; Tutsch K; Alberti D; Simon K; Hamilton RD; Bruggink J; Koeller JM; Tormey DC; Earhart RH
    Cancer Res; 1988 Oct; 48(19):5585-90. PubMed ID: 3416311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.
    Fischer PH; Willson JK; Risueno C; Tutsch K; Bruggink J; Ranhosky A; Trump DL
    Cancer Res; 1988 Oct; 48(19):5591-6. PubMed ID: 3416312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of antimetabolite action by dibromodulcitol in cell culture.
    Oláh E; Kremmer T; Boldizsár M
    Adv Enzyme Regul; 1985; 24():155-75. PubMed ID: 3835819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage pathways as targets of chemotherapy.
    Weber G; Jayaram HN; Pillwein K; Natsumeda Y; Reardon MA; Zhen YS
    Adv Enzyme Regul; 1987; 26():335-52. PubMed ID: 3673709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of lycurim and pyrazofurin on hepatoma 3924A cells in culture.
    Ban J; Olah E; Werber G
    Cancer Treat Rep; 1982 Feb; 66(2):343-9. PubMed ID: 6895716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of enzymic programs and nucleotide pattern in cancer cells by acivicin and tiazofurin.
    Weber G; Natsumeda Y; Lui MS; Faderan MA; Liepnieks JJ; Elliott WL
    Adv Enzyme Regul; 1984; 22():69-93. PubMed ID: 6206692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo inactivation by acivicin of carbamoyl-phosphate synthetase II in rat hepatoma.
    Aoki T; Sebolt J; Weber G
    Biochem Pharmacol; 1982 Mar; 31(6):927-32. PubMed ID: 7082374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation by acivicin of rat brain CTP and GMP synthetases and depression of CTP and GTP concentrations.
    Achleitner E; Lui MS; Weber G
    Adv Enzyme Regul; 1985; 24():225-32. PubMed ID: 3835820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ischemia on nucleosides and bases in rat liver and hepatoma 3924A.
    Pillwein K; Jayaram HN; Weber G
    Cancer Res; 1987 Jun; 47(12):3092-6. PubMed ID: 3581061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic and cell kinetic effects of 3,4,5-trihydroxybenzohydroxamic acid (VF 122) in hepatoma 3924A cells.
    Ban J; Olah E; Weber G
    Cancer Treat Rep; 1982 Dec; 66(12):2071-80. PubMed ID: 7139648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of dipyridamole on growth, nucleoside incorporation, and platelet-activating capability in the U87MG and SKNMC human tumor cell lines.
    Bastida E; del Prado J; Almirall L; Jamieson GA; Ordinas A
    Cancer Res; 1985 Sep; 45(9):4048-52. PubMed ID: 2992771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin B renders stationary phase hepatoma cells sensitive to dipyridamole.
    Zhen YS; Reardon MA; Weber G
    Biochem Biophys Res Commun; 1986 Oct; 140(1):434-9. PubMed ID: 3778458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.